Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Aug 2026, 01:57
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
RNBDENIMS experienced a quarterly acceleration in its Gross Margin, moving to 22.79%, up from 3.8%.
Revenue Growth Yoy also accelerated, reaching , up from -31.1%. Marginal Operating Leverage increased, moving to , up from 2.72%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 22.79 % | 3.8 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 3.8 % | 2.72 | ▲ |
| REVENUE_GROWTH_YOY | 16.3 % | -31.1 | ▲ |
| PRICE_CHANGE_PERCENT | -2.522 % | — | - |
| DAILY_VOLUME | 3,16,217 shares | 3,79,966 | ▼ |
| CLOSE_PRICE | 7.73 INR | 7.93 | ▼ |